Novo Nordisk cuts some U.S. supply of Wegovy obesity drug as demand soars

[ad_1]

Novo Nordisk said Thursday that it was cutting the supply of some doses of its popular obesity drug in the U.S. as it struggles to keep up with surging demand.

[ad_2]

Source link